Literature DB >> 27908535

Mortality profile of patients with rheumatoid arthritis in France and its change in 10 years.

Jérôme Avouac1, Fazia Amrouche2, Christophe Meune3, Grégoire Rey4, André Kahan2, Yannick Allanore2.   

Abstract

OBJECTIVE: To study the mortality profile of patients with rheumatoid arthritis (RA) in France.
METHODS: Data were collected between 2000 and 2011 from the French Epidemiological Center for the Medical Causes of Death database; all death certificates from adults that either mentioned RA as an underlying cause of death (UCD) or as an associated cause of death (ACD) were evaluated using multiple-cause-of-death analysis. The different causes of death and their frequency were reported, together with the ratio of observed/expected number of death (O/E ratio) to measure the strength of association between RA listed as an ACD and the corresponding UCD.
RESULTS: During the study period, 13,208 deaths related to RA were identified. The mean ± SD age at death was 79 ± 9 years (51% with ≥80 years) and the female/male ratio was 3.2. When RA was the UCD (n = 4597), the main causes of death were cardiovascular (29%) and infectious diseases (22%). When RA was an ACD (n = 8611), the most common UCDs were cardiovascular diseases (35%), neoplasms (14%), respiratory disease (9%), and infectious diseases (7%). The overall O/E ratio was >1 for infectious (3.58), respiratory (1.38), and cardiovascular diseases (1.25), but was <1 for neoplasms.
CONCLUSION: We provide the most recent national multiple-cause-of-death analysis assessing the mortality profile of RA patients. Our results show that mortality related to cardiovascular, respiratory, and infectious diseases is highly associated with RA. These data support the need to expand new strategies to prevent infectious and cardiovascular diseases in order to improve survival of RA patients.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular; Infectious diseases; Mortality; Neoplasm; Rheumatoid arthritis

Mesh:

Year:  2016        PMID: 27908535     DOI: 10.1016/j.semarthrit.2016.10.007

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  5 in total

Review 1.  Cardiovascular and Metabolic Comorbidities in Rheumatoid Arthritis.

Authors:  Silvio Romano; Elisa Salustri; Piero Ruscitti; Francesco Carubbi; Maria Penco; Roberto Giacomelli
Journal:  Curr Rheumatol Rep       Date:  2018-11-05       Impact factor: 4.592

2.  Prevalence of comorbidities in Mexican mestizo patients with rheumatoid arthritis.

Authors:  Dionicio A Galarza-Delgado; Jose R Azpiri-Lopez; Iris J Colunga-Pedraza; Jesus A Cárdenas-de la Garza; Raymundo Vera-Pineda; Martín Wah-Suárez; Rosa I Arvizu-Rivera; Adrian Martínez-Moreno; Ray E Ramos-Cázares; Francisco J Torres-Quintanilla; Aldo Valdovinos-Bañuelos; Jorge Antonio Esquivel-Valerio; Mario A Garza-Elizondo
Journal:  Rheumatol Int       Date:  2017-07-05       Impact factor: 2.631

3.  Rheumatoid Arthritis Interstitial Lung Disease: Measuring and Predictive Factors Among Patients Treated in Rehabilitation Clinics at Royal Medical Services.

Authors:  Deifallah Mohammad Alsharari; Laith Abdulsalam Obeidat; Hayat Khuzai Khasawneh; Moh'd Rami Hani Alhmar; Raja Mohammad Khasawneh; Zeyad Sulieman Bataineh; Ahmad Abdelqader Aldhoun
Journal:  Med Arch       Date:  2020-12

4.  Determination of the main causes, outcome, and prognostic factors of patients with rheumatologic diseases admitted to the medical intensive care unit in Southern Iran.

Authors:  Mojgan Arjmand; Reza Shahriarirad; Saeedeh Shenavandeh; Mohammad Javad Fallahi
Journal:  Clin Rheumatol       Date:  2022-08-15       Impact factor: 3.650

Review 5.  Rheumatoid arthritis and risk of cardiovascular disease.

Authors:  Pieter W Meyer; Ronald Anderson; James A Ker; Mahmood T Ally
Journal:  Cardiovasc J Afr       Date:  2018-03-27       Impact factor: 1.167

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.